Nisa Investment Advisors, LLC Enanta Pharmaceuticals Inc Transaction History

Nisa Investment Advisors, LLC

  • $16.7 Billion
  • Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 2,827 shares of ENTA stock, worth $26,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,827
Previous 2,886 2.04%
Holding current value
$26,404
Previous $37,000 21.62%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$10.05 - $16.54 $592 - $975
-59 Reduced 2.04%
2,827 $29,000
Q2 2024

Jul 19, 2024
BUY
$11.43 - $17.02 $674 - $1,004
59 Added 2.09%
2,886 $37,000
Q4 2023

Jan 25, 2024
BUY
$8.18 - $10.78 $18,658 - $24,589
2,281 Added 417.77%
2,827 $26,000
Q3 2023

Nov 02, 2023
BUY
$11.09 - $22.13 $399 - $796
36 Added 7.06%
546 $6,000
Q2 2023

Aug 11, 2023
BUY
$20.68 - $39.85 $6,886 - $13,270
333 Added 188.14%
510 $10,000
Q1 2023

May 02, 2023
SELL
$38.82 - $54.59 $29,115 - $40,942
-750 Reduced 80.91%
177 $7,000
Q4 2022

Feb 02, 2023
SELL
$40.77 - $53.73 $366 - $483
-9 Reduced 0.96%
927 $43,000
Q3 2022

Nov 07, 2022
SELL
$48.29 - $71.27 $13,086 - $19,314
-271 Reduced 22.45%
936 $42,000
Q2 2022

Aug 03, 2022
BUY
$38.13 - $76.93 $28,597 - $57,697
750 Added 164.11%
1,207 $57,000
Q1 2022

Apr 29, 2022
SELL
$56.06 - $74.11 $60,376 - $79,816
-1,077 Reduced 70.21%
457 $33,000
Q4 2021

Feb 03, 2022
SELL
$60.19 - $97.37 $173,708 - $281,009
-2,886 Reduced 65.29%
1,534 $91,000
Q3 2021

Oct 18, 2021
SELL
$41.02 - $58.65 $82,614 - $118,121
-2,014 Reduced 31.3%
4,420 $251,000
Q4 2020

Jan 25, 2021
BUY
$41.16 - $47.47 $113,683 - $131,112
2,762 Added 75.22%
6,434 $271,000
Q3 2020

Oct 20, 2020
BUY
$43.36 - $53.53 $131,467 - $162,302
3,032 Added 473.75%
3,672 $168,000
Q2 2020

Jul 27, 2020
BUY
$46.37 - $57.58 $23,185 - $28,790
500 Added 357.14%
640 $32,000
Q1 2020

Apr 17, 2020
BUY
$40.22 - $62.0 $2,011 - $3,100
50 Added 55.56%
140 $7,000
Q3 2018

Oct 16, 2018
BUY
$85.46 - $126.37 $7,691 - $11,373
90 New
90 $8,000

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email